PI3K/Akt/mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence

A Narayanankutty - Current drug targets, 2019 - ingentaconnect.com
Background: Phosphoinositide 3-kinase (PI3Ks) is a member of intracellular lipid kinases
and involved in the regulation of cellular proliferation, differentiation and survival …

Signaling pathways involved in colorectal cancer progression

Z Koveitypour, F Panahi, M Vakilian, M Peymani… - Cell & bioscience, 2019 - Springer
Colorectal cancer (CRC) is the fourth leading cause of the worldwide cancer mortality.
Different molecular mechanisms have been attributed to the development and progress of …

Emerging trends in colorectal cancer: Dysregulated signaling pathways

R Ahmad, JK Singh, A Wunnava… - International …, 2021 - spandidos-publications.com
Colorectal cancer (CRC) is the third most frequently detected type of cancer, and the second
most common cause of cancer-related mortality globally. The American Cancer Society …

[HTML][HTML] MicroRNA-21 (Mir-21) promotes cell growth and invasion by repressing tumor suppressor PTEN in colorectal cancer

Y Wu, Y Song, Y Xiong, X Wang, K Xu, B Han… - Cellular Physiology and …, 2017 - karger.com
Background/Aims: MicroRNA-21 (miR-21) has been demonstrated to play an important role
in carcinogenesis; however, its mechanism of action in colorectal cancer (CRC) has not …

MicroRNAs and apoptosis in colorectal cancer

H Wang - International journal of molecular sciences, 2020 - mdpi.com
Colorectal cancer (CRC) is the third leading cause of cancer death in the world, and its
incidence is rising in developing countries. Treatment with 5-Fluorouracil (5-FU) is known to …

Mechanism of apoptosis induced by curcumin in colorectal cancer

NI Ismail, I Othman, F Abas, N H. Lajis… - International journal of …, 2019 - mdpi.com
Colorectal cancer (CRC) is among the top three cancer with higher incident and mortality
rate worldwide. It is estimated that about over than 1.1 million of death and 2.2 million new …

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer

Y Mao, Q Feng, P Zheng, L Yang, T Liu… - Cancer management …, 2018 - Taylor & Francis
Purpose Tumor purity is defined as the proportion of cancer cells in the tumor tissue. The
impact of tumor purity on colon cancer (CC) prognosis, genetic profile, and …

Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer

MH Chen, YY Gu, AL Zhang, DM Sze, SL Mo… - Pharmacological …, 2021 - Elsevier
Abstract The plant Sophora flavescens Ait. has been used in the clinical management of
colorectal cancer (CRC). Its constituent compounds, notably the alkaloids matrine …

SNORD126 promotes HCC and CRC cell growth by activating the PI3K–AKT pathway through FGFR2

X Fang, D Yang, H Luo, S Wu, W Dong… - Journal of molecular …, 2017 - academic.oup.com
Small nucleolar RNA (snoRNA) dysfunctions have been associated with cancer
development. SNORD126 is an orphan C/D box snoRNA that is encoded within introns 5–6 …

In vitro and in vivo anticancer effects of syringic acid on colorectal cancer: Possible mechanistic view

A Mihanfar, SG Darband, S Sadighparvar… - Chemico-Biological …, 2021 - Elsevier
This study aimed to evaluate the in vitro effects of syringic acid on human colorectal cancer
cells (SW-480) and the effect of orally administered syringic acid on in vivo models of …